{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:52:56Z","timestamp":1785214376672,"version":"3.55.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"am","delay-in-days":300,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.coviro.2021.09.003","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T20:23:20Z","timestamp":1632774200000},"page":"34-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Antivirals targeting paramyxovirus membrane fusion"],"prefix":"10.1016","volume":"51","author":[{"given":"Erik M","family":"Contreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Abrrey","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ruvalcaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6879-8360","authenticated-orcid":false,"given":"Hector C","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2021.09.003_bib0005","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1017\/S095026881100238X","article-title":"Who are the children at risk? Lessons learned from measles outbreaks","volume":"140","author":"Stein-Zamir","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.coviro.2021.09.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g3478","article-title":"Rise in US measles cases is blamed on unimmunized travelers","volume":"348","author":"Tanne","year":"2014","journal-title":"Br Med J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0015","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(12)60522-4","article-title":"Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data","volume":"379","author":"Simons","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2021.09.003_bib0020","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.15585\/mmwr.mm6747a6","article-title":"Progress toward regional measles elimination - worldwide, 2000-2017","volume":"67","author":"Dabbagh","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2021.09.003_bib0025","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1086\/591196","article-title":"Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?","volume":"47","author":"Dayan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0030","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.15585\/mmwr.mm6742a4","article-title":"Measles outbreak in a highly vaccinated population - Israel, July-August 2017","volume":"67","author":"Avramovich","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2021.09.003_bib0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/335020a0","article-title":"Identification of virus causing recent seal deaths","volume":"335","author":"Osterhaus","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.09.003_bib0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/379441a0","article-title":"A canine distemper virus epidemic in Serengeti lions (Panthera leo)","volume":"379","author":"RoelkeParker","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.09.003_bib0045","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/JVI.02419-12","article-title":"Lethal canine distemper virus outbreak in cynomolgus monkeys in Japan in 2008","volume":"87","author":"Sakai","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-019-1136-6","article-title":"Tropism and molecular pathogenesis of canine distemper virus","volume":"16","author":"Rendon-Marin","year":"2019","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.oooo.2019.06.012","article-title":"Viral mumps: increasing occurrences in the vaccinated population","volume":"128","author":"Lau","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0060","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.288.5470.1432","article-title":"Nipah virus: a recently emergent deadly paramyxovirus","volume":"288","author":"Chua","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.09.003_bib0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1386-6532(02)00268-8","article-title":"Nipah virus outbreak in Malaysia","volume":"26","author":"Chua","year":"2003","journal-title":"J Clin Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0070","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1017\/S0950268810000695","article-title":"Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007","volume":"138","author":"Homaira","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.coviro.2021.09.003_bib0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3201\/eid1802.111492","article-title":"Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010","volume":"18","author":"Lo","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0080","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s13337-013-0171-y","article-title":"Nipah virus infection: current scenario","volume":"24","author":"Kulkarni","year":"2013","journal-title":"Indian J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3201\/eid1410.060507","article-title":"Risk factors for Nipah virus encephalitis in Bangladesh","volume":"14","author":"Montgomery","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0090","article-title":"The killer virus called Nipah: a review","volume":"10","author":"Ramphul","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0095","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3201\/eid2505.181076","article-title":"Nipah virus sequences from humans and bats during Nipah outbreak, Kerala, India, 2018","volume":"25","author":"Yadav","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0100","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/infdis\/jiy612","article-title":"Outbreak investigation of Nipah virus disease in Kerala, India, 2018","volume":"219","author":"Arunkumar","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0105","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ana.1062","article-title":"Treatment of acute Nipah encephalitis with ribavirin","volume":"49","author":"Chong","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jinf.2019.03.005","article-title":"First experience of ribavirin postexposure prophylaxis for Nipah virus, tried during the 2018 outbreak in Kerala, India","volume":"78","author":"Banerjee","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.coviro.2021.09.003_bib0120","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1099\/0022-1317-81-8-1927","article-title":"Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus","volume":"81","author":"Halpin","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1751-0813.2000.tb11758.x","article-title":"A fatal case of Hendra virus infection in a horse in north Queensland: clinical and epidemiological features","volume":"78","author":"Field","year":"2000","journal-title":"Aust Vet J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrmicro1323","article-title":"Hendra and Nipah viruses: different and dangerous","volume":"4","author":"Eaton","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0135","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3201\/eid2006.131022","article-title":"Novel Henipa-like virus, Mojiang Paramyxovirus, in rats, China, 2012","volume":"20","author":"Wu","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16060","article-title":"Idiosyncratic M\u00f2ji\u0101ng virus attachment glycoprotein directs a host-cell entry pathway distinct from genetically related henipaviruses","volume":"8","author":"Rissanen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.09.003_bib0145","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3201\/eid1408.071492","article-title":"Henipavirus infection in fruit bats (Pteropus giganteus), India","volume":"14","author":"Epstein","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0150","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1796","article-title":"Bats host major mammalian paramyxoviruses","volume":"3","author":"Drexler","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.09.003_bib0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/vbz.2018.2365","article-title":"Henipaviruses at the interface between bats, livestock and human population in Africa: a review","volume":"19","author":"Mbu\u2019u","year":"2019","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/vbz.2016.2051","article-title":"Antibodies against henipa-like viruses in Brazilian bats","volume":"17","author":"de Araujo","year":"2017","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/vim.2017.0143","article-title":"Measles vaccine","volume":"31","author":"Griffin","year":"2018","journal-title":"Viral Immunol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(06)68143-9","article-title":"Smallpox","volume":"367","author":"Moore","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2021.09.003_bib0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1126\/science.330.6003.435","article-title":"Animal science. Rinderpest, deadly for cattle, joins smallpox as a vanquished disease","volume":"330","author":"Normile","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.09.003_bib0180","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature10639","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"Muhlebach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.09.003_bib0185","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.1128\/JVI.00824-12","article-title":"Nectin4 is an epithelial cell receptor for canine distemper virus and involved in neurovirulence","volume":"86","author":"Pratakpiriya","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0190","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1128\/JVI.02792-12","article-title":"Characterization of ovine nectin-4, a novel peste des petits ruminants virus receptor","volume":"87","author":"Birch","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nature03838","article-title":"EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus","volume":"436","author":"Negrete","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.09.003_bib0200","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1074\/jbc.M807469200","article-title":"A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F)","volume":"284","author":"Aguilar","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2021.09.003_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002836","article-title":"Cedar virus: a novel henipavirus isolated from Australian bats","volume":"8","author":"Marsh","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.09.003_bib0210","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02458-13","article-title":"Surface glycoproteins of an African henipavirus induce syncytium formation in a cell line derived from an African fruit bat, Hypsignathus monstrosus","volume":"87","author":"Kr\u00fcger","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.virusres.2014.01.003","article-title":"Surface glycoproteins of the recently identified African henipavirus promote viral entry and cell fusion in a range of human, simian and bat cell lines","volume":"181","author":"Lawrence","year":"2014","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2021.09.003_bib0220","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00773-15","article-title":"Novel functions of Hendra virus G N-glycans and comparisons to Nipah virus","volume":"89","author":"Bradel-Tretheway","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0225","first-page":"E2156","article-title":"Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus","volume":"112","author":"Lee","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0230","doi-asserted-by":"crossref","first-page":"20707","DOI":"10.1073\/pnas.1911773116","article-title":"Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus","volume":"116","author":"Laing","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/v11090800","article-title":"Fusogenicity of the Ghana virus (Henipavirus: Ghanaian bat henipavirus) fusion protein is controlled by the cytoplasmic domain of the attachment glycoprotein","volume":"11","author":"Voigt","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2021.09.003_bib0240","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02427-14","article-title":"Heparan sulfate-dependent enhancement of henipavirus infection","volume":"6","author":"Mathieu","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2021.09.003_bib0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-5793(84)81359-9","article-title":"A novel-approach to the study of glycolipid receptors for viruses - binding of Sendai virus to thin-layer chromatograms","volume":"170","author":"Hansson","year":"1984","journal-title":"FEBS Lett"},{"key":"10.1016\/j.coviro.2021.09.003_bib0250","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.67.11.6463-6468.1993","article-title":"Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity","volume":"67","author":"Moscona","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0255","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/JVI.75.10.4604-4613.2001","article-title":"Receptor specificities of human respiroviruses","volume":"75","author":"Suzuki","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0260","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10719-006-5433-0","article-title":"Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview","volume":"23","author":"Villar","year":"2006","journal-title":"Glycoconj J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0265","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.tvjl.2005.12.004","article-title":"Blue eye disease porcine rubulavirus (PoRv) infects pig neurons and glial cells using sialo-glycoprotein as receptor","volume":"173","author":"Mendoza-Maga\u00f1a","year":"2007","journal-title":"Vet J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0270","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/glycob\/cwy053","article-title":"Addicted to sugar: roles of glycans in the order Mononegavirales","volume":"29","author":"Ortega","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.coviro.2021.09.003_bib0275","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.06350-11","article-title":"Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion","volume":"85","author":"Bose","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00863-3","article-title":"Monomeric ephrinB2 binding induces allosteric changes in Nipah virus G that precede its full activation","volume":"8","author":"Wong","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.09.003_bib0285","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.71.9.6287-6295.1997","article-title":"Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells","volume":"71","author":"Stone-Hulslander","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0290","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/jvi.71.1.650-656.1997","article-title":"Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces","volume":"71","author":"Yao","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0295","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.76.24.13028-13033.2002","article-title":"Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion","volume":"76","author":"Takimoto","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0300","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1128\/JVI.00190-06","article-title":"Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model","volume":"80","author":"Guillaume","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0305","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1128\/JVI.02205-06","article-title":"Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling","volume":"81","author":"Aguilar","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0310","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00152-17","article-title":"Mutations in the transmembrane domain and cytoplasmic tail of Hendra virus fusion protein disrupt virus-like-particle assembly","volume":"91","author":"Cifuentes-Mu\u00f1oz","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0315","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1099\/0022-1317-75-10-2821","article-title":"Correlation of proteolytic cleavage of F protein precursors in paramyxoviruses with expression of the fur, PACE4 and PC6 genes in mammalian cells","volume":"75","author":"Sakaguchi","year":"1994","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0320","doi-asserted-by":"crossref","first-page":"12714","DOI":"10.1128\/JVI.79.20.12714-12720.2005","article-title":"Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein","volume":"79","author":"Pager","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0325","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.virol.2006.01.007","article-title":"A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L","volume":"346","author":"Pager","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.09.003_bib0330","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1213802109","article-title":"Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein","volume":"109","author":"Welch","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_bib0335","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1128\/JVI.06628-11","article-title":"Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment","volume":"86","author":"Diederich","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0340","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0005-2736(03)00164-0","article-title":"Structure and function of a paramyxovirus fusion protein","volume":"1614","author":"Morrison","year":"2003","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.coviro.2021.09.003_bib0345","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/viro.2000.0817","article-title":"Paramyxovirus fusion (F) protein: a conformational change on cleavage activation","volume":"281","author":"Dutch","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0350","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11262-019-01713-8","article-title":"The DI-DII linker of human parainfluenza virus type 3 fusion protein is critical for the virus","volume":"56","author":"Liu","year":"2020","journal-title":"Virus Genes"},{"key":"10.1016\/j.coviro.2021.09.003_bib0355","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1128\/JVI.02754-14","article-title":"Measles virus glycoprotein complexes preassemble intracellularly and relax during transport to the cell surface in preparation for fusion","volume":"89","author":"Brindley","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0360","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1046\/j.1432-1327.2001.02166.x","article-title":"Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus","volume":"268","author":"Murakami","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.coviro.2021.09.003_bib0365","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01287-06","article-title":"Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH","volume":"80","author":"Schowalter","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0370","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1111\/j.1742-4658.2006.05459.x","article-title":"Crystal structures of Nipah and Hendra virus fusion core proteins","volume":"273","author":"Lou","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0375","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10409230802058320","article-title":"Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme","volume":"43","author":"White","year":"2008","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0380","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1523303113","article-title":"Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form","volume":"113","author":"Wong","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_bib0385","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.1998.9242","article-title":"A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41","volume":"248","author":"Joshi","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.09.003_bib0390","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00366-07","article-title":"A conserved region in the F2 subunit of paramyxovirus fusion proteins is involved in fusion regulation","volume":"81","author":"Gardner","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0395","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1021\/bi6025648","article-title":"A conserved region between the heptad repeats of paramyxovirus fusion proteins is critical for proper F protein folding","volume":"46","author":"Gardner","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.coviro.2021.09.003_bib0400","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s40588-016-0040-8","article-title":"Paramyxovirus glycoproteins and the membrane fusion process","volume":"3","author":"Aguilar","year":"2016","journal-title":"Curr Clin Microbiol Rep"},{"key":"10.1016\/j.coviro.2021.09.003_bib0405","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02022-06","article-title":"Identification of Hendra virus G glycoprotein residues that are critical for receptor binding","volume":"81","author":"Bishop","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0410","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1128\/JVI.02617-06","article-title":"A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism","volume":"81","author":"Porotto","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0415","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1128\/JVI.01469-16","article-title":"Multiple strategies reveal a bidentate interaction between the Nipah virus attachment and fusion glycoproteins","volume":"90","author":"Stone","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0420","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1083\/jcb.200305130","article-title":"A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion","volume":"163","author":"Russell","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0425","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01069-19","article-title":"Transmembrane domain dissociation is required for Hendra virus F protein fusogenic activity","volume":"93","author":"Slaughter","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0430","doi-asserted-by":"crossref","first-page":"E3018","DOI":"10.1073\/pnas.1210925109","article-title":"Triggering the measles virus membrane fusion machinery","volume":"109","author":"Brindley","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_bib0435","doi-asserted-by":"crossref","first-page":"12855","DOI":"10.1128\/JVI.06350-11","article-title":"Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion","volume":"85","author":"Bose","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0440","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.66.7.4564-4569.1992","article-title":"Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia","volume":"66","author":"Horvath","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0445","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1099\/0022-1317-78-4-775","article-title":"Paramyxovirus-induced syncytium cell formation is suppressed by a dominant negative fusion regulatory protein-1 (FRP-1)\/CD98 mutated construct: an important role of FRP-1 in virus-induced cell fusion","volume":"78","author":"Okamoto","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0450","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0002-9440(10)64493-8","article-title":"Nipah virus infection - pathology and pathogenesis of an emerging paramyxoviral zoonosis","volume":"161","author":"Wong","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005322","article-title":"Crystal structure of the pre-fusion Nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly","volume":"11","author":"Xu","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.09.003_bib0460","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2307\/1591531","article-title":"Avian paramyxovirus type-1 infections in racing pigeons in California .1. Clinical signs, pathology, and serology","volume":"36","author":"Barton","year":"1992","journal-title":"Avian Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0465","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virusres.2014.02.016","article-title":"Newcastle disease virus: current status and our understanding","volume":"184","author":"Ganar","year":"2014","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2021.09.003_bib0470","first-page":"794","article-title":"Nipah encephalitis: pathology and pathogenesis of a new, emerging paramyxovirus infection","volume":"10","author":"Wong","year":"2000","journal-title":"Brain Pathol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0475","doi-asserted-by":"crossref","first-page":"160","DOI":"10.20506\/rst.19.1.1202","article-title":"Nipah virus infection of pigs in peninsular Malaysia","volume":"19","author":"Mohd Nor","year":"2000","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.coviro.2021.09.003_bib0480","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(05)74483-4","article-title":"Malaysia culls pigs as Nipah virus strikes again","volume":"356","author":"Ahmad","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2021.09.003_bib0485","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(96)06162-4","article-title":"Fatal encephalitis due to novel paramyxovirus transmitted from horses","volume":"349","author":"O\u2019Sullivan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2021.09.003_bib0490","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1286-4579(01)01385-5","article-title":"Comparative pathology of the diseases caused hy Hendra and Nipah viruses","volume":"3","author":"Hooper","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.coviro.2021.09.003_bib0495","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/00006454-200107000-00003","article-title":"Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States","volume":"20","author":"Counihan","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0500","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.humpath.2003.11.012","article-title":"Pathology of parainfluenza virus infection in patients with congenital immunodeficiency syndromes","volume":"35","author":"Madden","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0505","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jpeds.2008.11.034","article-title":"Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization","volume":"154","author":"Weinberg","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.coviro.2021.09.003_bib0510","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jpids\/piu047","article-title":"Estimates of parainfluenza virus-associated hospitalizations and cost among children aged less than 5 years in the United States, 1998-2010","volume":"5","author":"Abedi","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.coviro.2021.09.003_bib0515","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/oxfordjournals.aje.a119992","article-title":"Observations on a mumps epidemic in a \u201cvirgin\u201d population","volume":"69","author":"Philip","year":"1959","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0520","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/jrf.0.0320491","article-title":"Sperm count, morphology and motility after unilateral mumps orchitis","volume":"32","author":"Bart\u00e1k","year":"1973","journal-title":"Reproduction"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0525","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0015-0282(16)41233-1","article-title":"Mumps oophoritis: a cause of premature menopause","volume":"26","author":"Morrison","year":"1975","journal-title":"Fertil Steril"},{"key":"10.1016\/j.coviro.2021.09.003_bib0530","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1464-410X.2009.09148.x","article-title":"The increasing incidence of mumps orchitis: a comprehensive review","volume":"105","author":"Davis","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.coviro.2021.09.003_bib0535","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.braindev.2014.09.006","article-title":"Prognosis and demographic characteristics of SSPE patients in Istanbul, Turkey","volume":"37","author":"Guler","year":"2015","journal-title":"Brain Dev"},{"key":"10.1016\/j.coviro.2021.09.003_bib0540","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/dmcn.14166","article-title":"Subacute sclerosing panencephalitis: clinical phenotype, epidemiology, and preventive interventions","volume":"61","author":"Mekki","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0545","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay6485","article-title":"Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens","volume":"366","author":"Mina","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.09.003_bib0550","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0021-9975(08)80210-1","article-title":"Pathology and epidemiology of canine distemper in raccoon dogs (Nyctereutes procyonoides)","volume":"108","author":"Machida","year":"1993","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0555","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0021-9975(85)90047-7","article-title":"Syncytia formation: an aid in the diagnosis of canine distemper encephalomyelitis","volume":"95","author":"Summers","year":"1985","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0560","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00401-004-0958-4","article-title":"Demyelination in canine distemper virus infection: a review","volume":"109","author":"Vandevelde","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0565","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cimid.2008.07.003","article-title":"Pathological and phylogenetic features of prevalent canine distemper viruses in wild masked palm civets in Japan","volume":"32","author":"Takayama","year":"2009","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0570","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1119972109","article-title":"Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats","volume":"109","author":"Woo","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0575","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vetmic.2019.04.027","article-title":"Feline morbillivirus in Northern Italy: prevalence in urine and kidneys with and without renal disease","volume":"233","author":"Stranieri","year":"2019","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0580","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1099\/vir.0.18962-0","article-title":"Isolation and partial characterization of a novel paramyxovirus from the gills of diseased seawater-reared Atlantic salmon (Salmo salar L.)","volume":"84","author":"Kvellestad","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0585","article-title":"Peste des petits ruminants virus enters caprine endometrial epithelial cells via the caveolae-mediated endocytosis pathway","volume":"9","author":"Yang","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0590","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1016\/j.vaccine.2007.02.013","article-title":"The threat of peste des petits ruminants: progress in vaccine development for disease control","volume":"25","author":"Diallo","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2021.09.003_bib0595","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1099\/0022-1317-78-1-107","article-title":"Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein","volume":"78","author":"Wild","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0600","first-page":"796","article-title":"Paramyxovirus-1 in feral pigeons (Columba livia) in Ontario","volume":"33","author":"Johnston","year":"1992","journal-title":"Can Vet J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0605","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22071190","article-title":"Antiviral lipopeptide-cell membrane interaction is influenced by PEG linker length","volume":"22","author":"Augusto","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.coviro.2021.09.003_bib0610","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.93.5.2186","article-title":"Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion","volume":"93","author":"Lambert","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_bib0615","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jac\/dkh161","article-title":"Clinical perspective of fusion inhibitors for treatment of HIV","volume":"53","author":"Rockstroh","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coviro.2021.09.003_bib0620","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd1331","article-title":"Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes","volume":"3","author":"Matthews","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coviro.2021.09.003_bib0625","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.coviro.2012.02.016","article-title":"Henipavirus outbreaks to antivirals: the current status of potential therapeutics","volume":"2","author":"Broder","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0630","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/viro.1996.0459","article-title":"Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection","volume":"223","author":"Yao","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.09.003_bib0635","doi-asserted-by":"crossref","first-page":"9837","DOI":"10.1128\/JVI.00736-06","article-title":"Inhibition of Hendra virus fusion","volume":"80","author":"Porotto","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0640","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01181-07","article-title":"Molecular determinants of antiviral potency of paramyxovirus entry inhibitors","volume":"81","author":"Porotto","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0645","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1128\/JVI.00416-09","article-title":"Kinetic dependence of paramyxovirus entry inhibition","volume":"83","author":"Porotto","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001168","article-title":"Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry","volume":"6","author":"Porotto","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.09.003_bib0655","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1128\/JVI.00135-10","article-title":"Viral entry inhibitors targeted to the membrane site of action","volume":"84","author":"Porotto","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036833","article-title":"A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity","volume":"7","author":"Pessi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2021.09.003_bib0665","doi-asserted-by":"crossref","DOI":"10.1038\/srep43610","article-title":"Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides","volume":"7","author":"Mathieu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2021.09.003_bib0670","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/infdis\/jiy152","article-title":"Fusion inhibitory lipopeptides engineered for prophylaxis of Nipah virus in primates","volume":"218","author":"Mathieu","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0675","doi-asserted-by":"crossref","first-page":"12648","DOI":"10.1021\/jacs.9b04615","article-title":"Dual inhibition of human parainfluenza type 3 and respiratory syncytial virus infectivity with a single agent","volume":"141","author":"Outlaw","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.coviro.2021.09.003_bib0680","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1021\/jacs.9b11548","article-title":"Structure-guided improvement of a dual HPIV3\/RSV fusion inhibitor","volume":"142","author":"Outlaw","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.coviro.2021.09.003_bib0685","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JVI.02417-14","article-title":"Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides","volume":"89","author":"Mathieu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0690","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/acsinfecdis.0c00385","article-title":"Effects of single alpha-to-beta residue replacements on recognition of an extended segment in a viral fusion protein","volume":"6","author":"Outlaw","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0695","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1093\/emboj\/20.15.4024","article-title":"Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion","volume":"20","author":"Russell","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0700","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02436-13","article-title":"Fatal measles virus infection prevented by brain-penetrant fusion inhibitors","volume":"87","author":"Welsch","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0705","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01554-16","article-title":"In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence","volume":"91","author":"Figueira","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0710","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22111869","article-title":"Biophysical properties and antiviral activities of measles fusion protein derived peptide conjugated with 25-hydroxycholesterol","volume":"22","author":"Gomes","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.coviro.2021.09.003_bib0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162823","article-title":"A novel peptide derived from the fusion protein heptad repeat inhibits replication of subacute sclerosing panencephalitis virus in vitro and in vivo","volume":"11","author":"Watanabe","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2021.09.003_bib0720","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jviromet.2013.12.022","article-title":"In vitro and in vivo broad antiviral activity of peptides homologous to fusion glycoproteins of Newcastle disease virus and Marek\u2019s disease virus","volume":"199","author":"Chi","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0725","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00863-19","article-title":"A hydrophobic target: using the paramyxovirus fusion protein transmembrane domain to modulate fusion protein stability","volume":"93","author":"Barrett","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0730","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1002\/j.1460-2075.1995.tb00239.x","article-title":"A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion - an emerging similarity with functional domains of other viruses","volume":"14","author":"Rapaport","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2021.09.003_bib0735","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2012.08.012","article-title":"Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies","volume":"37","author":"Kwong","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2021.09.003_bib0740","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1128\/JVI.00193-11","article-title":"Interactions of human complement with virus particles containing the Nipah virus glycoproteins","volume":"85","author":"Johnson","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0745","doi-asserted-by":"crossref","first-page":"25057","DOI":"10.1073\/pnas.1912503116","article-title":"A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex","volume":"116","author":"Avanzato","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0750","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.bbrc.2019.03.212","article-title":"Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody","volume":"513","author":"Bae","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coviro.2021.09.003_bib0755","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.80.2.891-899.2006","article-title":"Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies","volume":"80","author":"Zhu","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000642","article-title":"A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection","volume":"5","author":"Bossart","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.09.003_bib0765","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/528801","article-title":"Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody","volume":"197","author":"Zhu","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0770","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008929","article-title":"Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody","volume":"6","author":"Geisbert","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2021.09.003_bib0775","doi-asserted-by":"crossref","DOI":"10.1038\/srep30916","article-title":"Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: implications for antibody therapy","volume":"6","author":"Mire","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2021.09.003_bib0780","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002901","article-title":"A neutralizing human monoclonal antibody protects African green monkeys from Hendra virus challenge","volume":"3","author":"Bossart","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0785","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41594-019-0308-9","article-title":"An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections","volume":"26","author":"Dang","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006837","article-title":"Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins","volume":"14","author":"Mousa","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0795","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00342-19","article-title":"A potent neutralizing site III-specific human antibody neutralizes human metapneumovirus in vivo","volume":"93","author":"Bar-Peled","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0800","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/jiu307","article-title":"A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus","volume":"211","author":"Schuster","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0805","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00106-07","article-title":"A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo","volume":"81","author":"Williams","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0810","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nsmb.2250","article-title":"Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site","volume":"19","author":"Wen","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0815","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41423-021-00691-y","article-title":"Single-chain variable fragment antibody constructs neutralize measles virus infection in vitro and in vivo","volume":"18","author":"Mathieu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0820","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0042-6822(89)90508-4","article-title":"Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies","volume":"171","author":"Tsurudome","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.09.003_bib0825","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1006\/viro.1995.1035","article-title":"A cell fusion-inhibiting monoclonal antibody binds to the presumed stalk domain of the human parainfluenza type 2 virus hemagglutinin-neuraminidase protein","volume":"206","author":"Yuasa","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.09.003_bib0830","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1128\/JVI.00460-08","article-title":"Effects of hemagglutinin-neuraminidase protein mutations on cell-cell fusion mediated by human parainfluenza type 2 virus","volume":"82","author":"Tsurudome","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0835","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01448-15","article-title":"The fusion protein specificity of the parainfluenza virus hemagglutinin-neuraminidase protein is not solely defined by the primary structure of its stalk domain","volume":"89","author":"Tsurudome","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0840","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1128\/JVI.01707-14","article-title":"Probing the functions of the paramyxovirus glycoproteins F and HN with a panel of synthetic antibodies","volume":"88","author":"Welch","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0845","doi-asserted-by":"crossref","first-page":"E3844","DOI":"10.1073\/pnas.1608349113","article-title":"Immobilization of the N-terminal helix stabilizes prefusion paramyxovirus fusion proteins","volume":"113","author":"Song","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_bib0850","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF01379094","article-title":"Multiple amino-acid substitutions in the HN protein of the paramyxovirus, SV-5, are selected for in monoclonal-antibody resistant mutants","volume":"131","author":"Baty","year":"1993","journal-title":"Arch Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0855","doi-asserted-by":"crossref","first-page":"37945","DOI":"10.1074\/jbc.M111.256248","article-title":"Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery","volume":"286","author":"Farzan","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0860","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02900-18","article-title":"Inhibiting human parainfluenza virus infection by preactivating the cell entry mechanism","volume":"10","author":"Bottom-Tanzer","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2021.09.003_bib0865","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03203-19","article-title":"Hijacking the fusion complex of human parainfluenza virus as an antiviral strategy","volume":"11","author":"Marcink","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2021.09.003_bib0870","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.74.23.11108-11114.2000","article-title":"The anti-influenza virus agent 4-GU-DANA (Zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA","volume":"74","author":"Greengard","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0875","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.80.3.1204-1213.2006","article-title":"Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site","volume":"80","author":"Porotto","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0880","doi-asserted-by":"crossref","first-page":"13911","DOI":"10.1128\/JVI.78.24.13911-13919.2004","article-title":"Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites","volume":"78","author":"Porotto","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0885","doi-asserted-by":"crossref","first-page":"S480","DOI":"10.1093\/infdis\/jiz630","article-title":"Griffithsin inhibits Nipah virus entry and fusion and can protect Syrian golden hamsters from lethal Nipah virus challenge","volume":"221","author":"Lo","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0890","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1128\/JVI.01362-16","article-title":"Inhibition of human metapneumovirus binding to heparan sulfate blocks infection in human lung cells and airway tissues","volume":"90","author":"Klimyte","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0895","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00425-015-2277-5","article-title":"HRA2pl peptide: a fusion inhibitor for human metapneumovirus produced in tobacco plants by transient transformation","volume":"242","author":"Marquez-Escobar","year":"2015","journal-title":"Planta"},{"key":"10.1016\/j.coviro.2021.09.003_bib0900","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/cid\/ciz1166","article-title":"A phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients","volume":"71","author":"Chemaly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2021.09.003_bib0905","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1401184","article-title":"Oral GS-5806 activity in a respiratory syncytial virus challenge study","volume":"371","author":"DeVincenzo","year":"2014","journal-title":"New Eng J Med"},{"key":"10.1016\/j.coviro.2021.09.003_bib0910","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1128\/AAC.00761-15","article-title":"GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion protein","volume":"59","author":"Samuel","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2021.09.003_bib0915","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0308520101","article-title":"A target site for template-based design of measles virus entry inhibitors","volume":"101","author":"Plemper","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_bib0920","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.49.9.3755-3761.2005","article-title":"Design of a small-molecule entry inhibitor with activity against primary measles virus strains","volume":"49","author":"Plemper","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2021.09.003_bib0925","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1718957115","article-title":"Structures of the prefusion form of measles virus fusion protein in complex with inhibitors","volume":"115","author":"Hashiguchi","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_bib0930","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0042-6822(80)90168-3","article-title":"Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the Fl or HA2 viral polypeptides","volume":"105","author":"Richardson","year":"1980","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.09.003_bib0935","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/JVI.80.3.1524-1536.2006","article-title":"Two domains that control prefusion stability and transport competence of the measles virus fusion protein","volume":"80","author":"Doyle","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0940","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01026-17","article-title":"Mutations in the fusion protein of measles virus that confer resistance to the membrane fusion inhibitors carbobenzoxy-D-Phe-L-Phe-Gly and 4-nitro-2-phenylacetyl amino-benzamide","volume":"91","author":"Ha","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0945","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.0909587107","article-title":"A broad-spectrum antiviral targeting entry of enveloped viruses","volume":"107","author":"Wolf","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.09.003_bib0950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003297","article-title":"A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion","volume":"9","author":"Vigant","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.09.003_bib0955","doi-asserted-by":"crossref","first-page":"67","DOI":"10.35772\/ghm.2020.01117","article-title":"COVID-19 and bronchial asthma: current perspectives","volume":"3","author":"Hojo","year":"2021","journal-title":"Glob Health Med"},{"key":"10.1016\/j.coviro.2021.09.003_bib0960","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0965","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.09.003_bib0970","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084067","article-title":"Pharmacological modulators of autophagy as a potential strategy for the treatment of COVID-19","volume":"22","author":"Pereira","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0975","article-title":"A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice","author":"Shapira","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.coviro.2021.09.003_bib0980","doi-asserted-by":"crossref","first-page":"11930","DOI":"10.1128\/JVI.01490-13","article-title":"TMPRSS2 is an activating protease for respiratory parainfluenza viruses","volume":"87","author":"Abe","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.09.003_sbref0985","doi-asserted-by":"crossref","first-page":"905","DOI":"10.15585\/mmwr.mm6841e1","article-title":"Vaccination coverage with selected vaccines and exemption rates among children in Kindergarten - United States, 2018-19 school year","volume":"68","author":"Seither","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2021.09.003_bib0990","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2021.09.003_bib0995","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02181-16","article-title":"Inhibition of an aquatic rhabdovirus demonstrates promise of a broad-spectrum antiviral for use in aquaculture","volume":"91","author":"Balmer","year":"2017","journal-title":"J Virol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625721001012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625721001012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:05:36Z","timestamp":1761818736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625721001012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":199,"alternative-id":["S1879625721001012"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2021.09.003","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antivirals targeting paramyxovirus membrane fusion","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2021.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}